A phase II study of XL184 in patients (pts) with progressive glioblastoma multiforme (GBM) in first or second relapse

被引：0
|
作者：
De Groot, J. F. [1 ,2 ,3 ,4 ,5 ]
Prados, M. [1 ,2 ,3 ,4 ,5 ]
Urquhart, T. [1 ,2 ,3 ,4 ,5 ]
Robertson, S. [1 ,2 ,3 ,4 ,5 ]
Yaron, Y. [1 ,2 ,3 ,4 ,5 ]
Sorensen, A. G. [1 ,2 ,3 ,4 ,5 ]
Norton, A. [1 ,2 ,3 ,4 ,5 ]
Batchelor, T. [1 ,2 ,3 ,4 ,5 ]
Drappatz, J. [1 ,2 ,3 ,4 ,5 ]
Wen, P. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Exelixis Inc, San Francisco, CA USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2047
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Correlative tumor molecular profiling and plasma biomarker analysis in a phase II study of XL184 in patients with progressive or recurrent glioblastoma multiforme (GBM)
    DePrimo, S.
    Wu, B.
    Huang, S.
    Bautista, R.
    Cancilla, B.
    Vysotskaia, V.
    De Groot, J.
    Prados, M.
    Buller, R.
    Wen, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Phase II study of XL184 (BMS 907351), an inhibitor of MET, VEGFR2, and RET, in patients (pts) with progressive glioblastoma (GB)
    Wen, P. Y.
    Prados, M.
    Schiff, D.
    Reardon, D. A.
    Cloughesy, T.
    Mikkelsen, T.
    Batchelor, T.
    Drappatz, J.
    Chamberlain, M. C.
    De Groot, J. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Phase 2 results of XL184 in a cohort of patients (pts) with advanced melanoma
    Nechushtan, H.
    Edelman, G.
    Jerusalem, G.
    Gordon, M.
    Kluger, H. M.
    Moussa, A.
    Ron, I.
    Schimmoller, F.
    Shen, X.
    Daud, A.
    EJC SUPPLEMENTS, 2010, 8 (07): : 126 - 127
  • [4] A phase II study of cabozantinib (XL184) in patients with advanced/metastatic urothelial carcinoma
    Apolo, Andrea Borghese
    Parnes, Howard L.
    Madan, Ravi Amrit
    Gulley, James L.
    Wright, John Joseph
    Khadar, Kattie
    Trepel, Jane B.
    Schlom, Jeffrey
    Arlen, Philip M.
    Merino, Maria
    Steinberg, Seth M.
    Choyke, Peter L.
    Lindenberg, Maria Liza
    Kurdziel, Karen A.
    Folio, Les
    Figg, William Douglas
    Agarwal, Piyush K.
    Bottaro, Donald P.
    Dahut, William L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Phase 2 study of XL184 in a cohort of ovarian cancer patients (pts) with measurable soft tissue disease
    Vergote, I.
    Sella, A.
    Bedell, C.
    Ramondetta, L.
    Shapiro, G. I.
    Balic, K.
    Prokopczuk, E.
    Sauer, L.
    Tseng, L.
    Berger, R.
    EJC SUPPLEMENTS, 2010, 8 (07): : 129 - 129
  • [6] Phase 2 study of XL184 (BMS-907351) in a cohort of patients (pts) with hepatocellular carcinoma (HCC)
    Van Cutsem, E.
    Su, W. C.
    Davis, J.
    Haas, N.
    Samuel, T. A.
    Tsao, C. J.
    Yang, T. S.
    Brandy, H.
    Mann, G.
    Cohn, A.
    EJC SUPPLEMENTS, 2010, 8 (07): : 129 - 130
  • [7] Phase II study of XL184 in a cohort of patients (pts) with castration-resistant prostate cancer (CRPC) and measurable soft tissue disease
    Smith, D. C.
    Smith, M. R.
    Small, E. J.
    Sweeney, C.
    Kurzrock, R.
    Gordon, M. S.
    Vogelzang, N. J.
    Scheffold, C.
    Ballinger, M. D.
    Hussain, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [8] A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
    Yung, WKA
    Albright, RE
    Olson, J
    Fredericks, R
    Fink, K
    Prados, MD
    Brada, M
    Spence, A
    Hohl, RJ
    Shapiro, W
    Glantz, M
    Greenberg, H
    Selker, RG
    Vick, NA
    Rampling, R
    Friedman, H
    Phillips, P
    Bruner, J
    Yue, N
    Osoba, D
    Zaknoen, S
    Levin, VA
    BRITISH JOURNAL OF CANCER, 2000, 83 (05) : 588 - 593
  • [9] A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
    W K A Yung
    R E Albright
    J Olson
    R Fredericks
    K Fink
    M D Prados
    M Brada
    A Spence
    R J Hohl
    W Shapiro
    M Glantz
    H Greenberg
    R G Selker
    N A Vick
    R Rampling
    H Friedman
    P Phillips
    J Bruner
    N Yue
    D Osoba
    S Zaknoen
    V A Levin
    British Journal of Cancer, 2000, 83 : 588 - 593
  • [10] Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
    Brada, M
    Hoang-Xuan, K
    Rampling, R
    Dietrich, PY
    Dirix, LY
    Macdonald, D
    Heimans, JJ
    Zonnenberg, BA
    Bravo-Marques, JM
    Henriksson, R
    Stupp, R
    Yue, N
    Bruner, J
    Dugan, M
    Rao, S
    Zaknoen, S
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 259 - 266
12345